{
    "clinical_study": {
        "@rank": "107756", 
        "arm_group": [
            {
                "arm_group_label": "Methylphenidate", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Enalapril", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether differences in the gene coding for the\n      liver enzyme carboxylesterase 1 (CES1) means differences in the metabolism of two CES1\n      dependent drugs, enalapril and methylphenidate."
        }, 
        "brief_title": "Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype", 
        "condition": [
            "Carboxylesterase 1 (CES1) Genotype", 
            "CES1 Activity"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  > 18 years old\n\n          -  Caucasian\n\n        Exclusion Criteria:\n\n          -  Chronic disease (except hay fever and eczema)\n\n          -  Pregnancy\n\n          -  Smoking\n\n          -  High level of alcohol consumption (> 21 units per week for men and 14 for women)\n\n          -  Known allergy towards methylphenidate and enalapril\n\n          -  Permanent use of medication (contraception ok)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02135263", 
            "org_study_id": "INDICES-WP2"
        }, 
        "intervention": [
            {
                "arm_group_label": "Methylphenidate", 
                "description": "10 mg as a single dose followed by blood samples for the next 33 hours", 
                "intervention_name": "Methylphenidate", 
                "intervention_type": "Drug", 
                "other_name": "Ritalin"
            }, 
            {
                "arm_group_label": "Enalapril", 
                "description": "10 mg as a single dose followed by blood samples for the next 72 hours", 
                "intervention_name": "Enalapril", 
                "intervention_type": "Drug", 
                "other_name": "Corodil"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Enalapril", 
                "Enalaprilat", 
                "Methylphenidate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 8, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2400"
                }, 
                "name": "Department of Clinical Pharmacology, Bispebjerg University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype", 
        "overall_official": {
            "affiliation": "Department of Clinical Pharmacology, Bispebjerg University Hospital", 
            "last_name": "Gesche J\u00fcrgens, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Peak plasma concentration (Cmax) of methylphenidate", 
                "safety_issue": "No", 
                "time_frame": "Predose, \u00bd, 1, 1\u00bd, 2, 2\u00bd, 3, 4, 6, 8, 10, 24 and 33 hours post-dose"
            }, 
            {
                "measure": "Time to peak plasma concentration (Tmax) of methylphenidate", 
                "safety_issue": "No", 
                "time_frame": "Predose, \u00bd, 1, 1\u00bd, 2, 2\u00bd, 3, 4, 6, 8, 10, 24 and 33 hours post-dose"
            }, 
            {
                "measure": "Terminal half life (t\u00bd) of methylphenidate", 
                "safety_issue": "No", 
                "time_frame": "Predose, \u00bd, 1, 1\u00bd, 2, 2\u00bd, 3, 4, 6, 8, 10, 24 and 33 hours post-dose"
            }, 
            {
                "measure": "Area under the plasma concentration versus time curve (AUC) of methylphenidate", 
                "safety_issue": "No", 
                "time_frame": "Predose, \u00bd, 1, 1\u00bd, 2, 2\u00bd, 3, 4, 6, 8, 10, 24 and 33 hours post-dose"
            }, 
            {
                "measure": "Peak plasma concentration (Cmax) of enalapril", 
                "safety_issue": "No", 
                "time_frame": "Predose, \u00bd, 1, 2, 3, 4, 5, 6, 9, 24, 48 and 72 hours post-dose"
            }, 
            {
                "measure": "Time to peak plasma concentration (Tmax) of enalapril", 
                "safety_issue": "No", 
                "time_frame": "Predose, \u00bd, 1, 2, 3, 4, 5, 6, 9, 24, 48 and 72 hours post-dose"
            }, 
            {
                "measure": "Terminal half life (t\u00bd) of enalapril", 
                "safety_issue": "No", 
                "time_frame": "Predose, \u00bd, 1, 2, 3, 4, 5, 6, 9, 24, 48 and 72 hours post-dose"
            }, 
            {
                "measure": "Area under the plasma concentration versus time curve (AUC) of enalapril", 
                "safety_issue": "No", 
                "time_frame": "Predose, \u00bd, 1, 2, 3, 4, 5, 6, 9, 24, 48 and 72 hours post-dose"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02135263"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bispebjerg Hospital", 
            "investigator_full_name": "Gesche Jurgens", 
            "investigator_title": "M.D., Ph.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Four samples for each participant during the methylphenidate trials (as indicated above). Metabolomics will be assessed with focus on lipids (lipid platform) and with use of usual concentration measures (eg nanomolar (nM))", 
            "measure": "Metabolomic profile", 
            "safety_issue": "No", 
            "time_frame": "Predose/pre-meal, predose/post-meal, 2 and 6 hours post-dose"
        }, 
        "source": "Bispebjerg Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Ministry of Science, Innovation and Higher Education (Denmark)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Mental Health Centre Sct. Hans (Denmark)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Copenhagen", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "The Leiden Academic Center for Drug Research (LACDR)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Duke University School of Medicine", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Bispebjerg Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}